DAB2 and pancreatic neoplasm: These results indicate that Dab2 promoter methylation may play a more prominent role in modulation of Dab2 expression early in pancreatic cancer progression while other mechanisms for decreased Dab2 expression may predominate in later stages of pancreatic cancer.